INVERNIZZI PIETRO

Massironi, S., Franchina, M., Ippolito, D., Elisei, F., Falco, O., Maino, C., et al. (2024). Improvements and future perspective in diagnostic tools for neuroendocrine neoplasms. EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 19(4), 349-366 [10.1080/17446651.2024.2363537]. Detail

Massironi, S., Elvevi, A., Panceri, R., Mulinacci, G., Colella, G., Biondi, A., et al. (2024). Eosinophilic esophagitis: does age matter?. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 20(2), 211-223 [10.1080/1744666X.2023.2274940]. Detail

Ciardullo, S., Mantovani, A., Morieri, M., Muraca, E., Invernizzi, P., Perseghin, G. (2024). Impact of MASLD and MetALD on clinical outcomes: A meta-analysis of preliminary evidence. LIVER INTERNATIONAL [10.1111/liv.15939]. Detail

Riva, M., Valnegri, C., Invernizzi, P. (2024). The liver in Christian thought: Symbolism, morality, and spirituality. CLINICAL LIVER DISEASE, 23(1) [10.1097/cld.0000000000000236]. Detail

Corpechot, C., Lemoinne, S., Soret, P., Hansen, B., Hirschfield, G., Gulamhusein, A., et al. (2024). Adequate versus deep response to ursodeoxycholic acid in primary biliary cholangitis: To what extent and under what conditions is normal alkaline phosphatase level associated with complication-free survival gain?. HEPATOLOGY, 79(1), 39-48 [10.1097/HEP.0000000000000529]. Detail